CLIMB BIO INC
CLYM·28658R106·US·Common Stock·Healthcare - Biotechnology-Activist
CLYM (CLIMB BIO INC) is held by 51 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($77.4M), PRICE T ROWE ASSOCIATES INC /MD/ ($13.1M), MILLENNIUM MANAGEMENT LLC ($8.7M). Net institutional sentiment: Bullish.
51
Holders
(3 Elite)
$145.9M
Total Value
68% (50)
Consensus
34 buying - 16 selling
13F: Insider & Congress:
Who's Trading
InsiderTBThomas Stephen BasilSell $114KFeb 26, 2026
InsiderTBThomas Stephen BasilSell $236KFeb 25, 2026
ActivistMBMPM BioImpact LLC5.6%Feb 17, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $25KJan 5, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $290KDec 12, 2025
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $465KDec 11, 2025
ActivistAEAI ETI LLC0.0%Oct 16, 2025
Showing 1-20 of 54
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer